A224

THE CODI Co.,LTD. Stock Price

KOSDAQ:A224060 Community·₩15.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A224060 Share Price Performance

₩3,010.00
-1895.00 (-38.63%)
₩3,010.00
-1895.00 (-38.63%)
Price ₩3,010.00

A224060 Community Narratives

There are no narratives available yet.

Recent A224060 News & Updates

THE CODI Co.,LTD.'s (KOSDAQ:224060) Share Price Is Matching Sentiment Around Its Revenues

Apr 17
THE CODI Co.,LTD.'s (KOSDAQ:224060) Share Price Is Matching Sentiment Around Its Revenues

THE CODI Co.,LTD.'s (KOSDAQ:224060) Revenues Are Not Doing Enough For Some Investors

Jan 08
THE CODI Co.,LTD.'s (KOSDAQ:224060) Revenues Are Not Doing Enough For Some Investors

Health Check: How Prudently Does CODILTD (KOSDAQ:224060) Use Debt?

Oct 14
Health Check: How Prudently Does CODILTD (KOSDAQ:224060) Use Debt?

THE CODI Co.,LTD.'s (KOSDAQ:224060) Popularity With Investors Is Under Threat From Overpricing

Aug 13
THE CODI Co.,LTD.'s (KOSDAQ:224060) Popularity With Investors Is Under Threat From Overpricing

What THE CODI Co.,LTD.'s (KOSDAQ:224060) P/S Is Not Telling You

Mar 12
What THE CODI Co.,LTD.'s (KOSDAQ:224060) P/S Is Not Telling You

THE CODI Co.,LTD. Key Details

₩33.4b

Revenue

₩27.9b

Cost of Revenue

₩5.5b

Gross Profit

₩10.6b

Other Expenses

-₩5.1b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-993.15
Gross Margin
16.44%
Net Profit Margin
-15.26%
Debt/Equity Ratio
249.2%

THE CODI Co.,LTD. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

1 Risk
0 Rewards

About A224060

Founded
1999
Employees
39
CEO
n/a
WebsiteView website
codi-m.com

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agent for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. The company was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was founded in 1999 and is headquartered in Cheonan-si, South Korea.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

South Korean Market Performance

  • 7 Days: -0.006%
  • 3 Months: 11.7%
  • 1 Year: 32.9%
  • Year to Date: 44.6%
The market has stayed flat over the 7 days. More promisingly, the market is up 33% over the past year. As for the next few years, earnings are expected to grow by 24% per annum. Market details ›